moderate-to-high - Revenue depends on small business healthcare practice health and willingness to invest in software. During recessions, dental/optometry/veterinary visits decline as consumers defer discretionary healthcare spending, pressuring practice revenues and software budgets. New customer acquisition slows as practices delay technology investments. However, existing customers exhibit stickiness due to workflow integration. SMB-focused SaaS companies typically see 200-300bps churn rate increases during downturns.

Rising rates create multiple headwinds: (1) Higher discount rates compress valuation multiples for unprofitable growth software companies disproportionately (stock trades at 1.9x sales vs 5-8x for profitable SaaS peers), (2) Reduced venture capital funding for potential acquisition exits, (3) Tighter credit conditions for SMB customers may reduce technology spending budgets. However, minimal direct impact on operations given low debt levels (0.67x D/E) and no significant refinancing needs near-term.

growth - Investors seeking exposure to vertical SaaS secular growth trends with tolerance for near-term losses and execution risk. The 67% one-year decline has created a distressed valuation scenario attracting deep value/turnaround investors betting on path to profitability. High risk/high reward profile given small market cap, negative profitability, and competitive intensity. Not suitable for income or conservative growth investors given no dividends and significant cash burn.